Earnings Labs
SCYNEXIS, Inc. logo

SCYNEXIS, Inc. (SCYX) Earnings Dates & History

NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic

$0.99

-1.23%

Mkt Cap $36.09M

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Mar 4, 2026

$8.10M$18.65M+130.20%$0.13$0.25+97.32%
Q4 2025

Nov 5, 2025

$8.10M$334.00K-95.88%-$0.21-$0.17+19.05%
Q3 2025

Aug 13, 2025

$154.00K$1.36M+785.71%-$0.23-$0.14+39.13%
Q2 2025

May 15, 2025

$137.00K$257.00K+87.59%-$0.23-$0.17+26.09%
Q1 2025

Mar 12, 2025

$10.19M$977.00K-90.41%-$0.22-$0.09+59.09%
Q4 2024

Nov 6, 2024

$9.23M$660.00K-92.85%-$0.20-$0.06+70.00%
Q3 2024

Aug 8, 2024

$12.23M$736.00K-93.98%-$0.19-$0.30-57.89%
Q2 2024

May 8, 2024

$5.35M$1.37M-74.34%-$0.18-$0.15+16.67%
Q1 2024

Mar 28, 2024

$1.37M$5.80M+323.14%$0.31-$0.39-225.81%
Q4 2023

Nov 13, 2023

$1.37M$1.76M+28.54%$0.29-$0.04-113.79%
Q3 2023

Aug 14, 2023

$95.45M$131.45M+37.72%$1.55$2.46+58.71%
Q2 2023

May 11, 2023

$90.40M$1.13M-98.75%-$0.28-$0.25+10.71%
Q1 2023

Mar 31, 2023

$1.57M$1.52M-2.93%-$0.50-$0.29+42.00%
Q4 2022

Nov 9, 2022

$2.11M$1.56M-26.19%-$0.51-$0.62-21.57%
Q3 2022

Aug 15, 2022

$1.68M$1.32M-21.17%-$0.57-$0.53+7.02%
Q2 2022

May 12, 2022

$1.09M$687.00K-36.97%-$0.74-$0.51+31.08%
Q1 2022

Mar 29, 2022

$1.26M$597.00K-52.59%-$0.71-$1.05-47.89%
Q4 2021

Nov 10, 2021

$893.53K$516.00K-42.25%-$0.79-$0.06+92.41%
Q3 2021

Aug 16, 2021

$370.00K-$0.58-$0.22+62.07%
Q2 2021

May 17, 2021

$18.82M$12.05M-35.97%-$0.68-$0.23+66.18%
Q1 2021

Mar 29, 2021

-$0.78-$1.47-88.46%
Q4 2020

Nov 6, 2020

-$1.07-$0.28+73.83%
Q3 2020

Aug 10, 2020

-$1.10-$0.64+41.82%
Q2 2020

May 11, 2020

-$1.40-$1.10+21.43%
Q1 2020

Mar 11, 2020

$104.50K-$1.30-$1.80-38.46%
Q4 2019

Nov 12, 2019

$191.87K-$2.20-$2.10+4.55%
Q3 2019

Aug 7, 2019

$68.40K$57.00K-16.67%-$1.80-$1.60+11.11%
Q2 2019

May 8, 2019

$51.20K$64.00K+25.00%-$2.00-$2.40-20.00%
Q1 2019

Mar 14, 2019

$151.47K$64.00K-57.75%-$0.90-$0.40+55.56%
Q4 2018

Nov 13, 2018

$1.14M$64.00K-94.38%-$2.00-$1.40+30.00%
Q3 2018

Aug 9, 2018

$48.89K$64.00K+30.90%-$1.40-$2.30-64.29%
Q2 2018

May 8, 2018

$101.33K$64.00K-36.84%-$1.90-$1.20+36.84%
Q1 2018

Mar 13, 2018

$66.37K$64.00K-3.57%-$0.28-$2.70-864.29%
Q4 2017

Nov 7, 2017

$68.13K$64.00K-6.06%-$3.00-$2.70+10.00%
Q3 2017

Aug 8, 2017

$125.94K$64.00K-49.18%-$3.40-$1.60+52.94%
Q2 2017

May 8, 2017

$107.79K$64.00K-40.62%-$3.70-$2.10+43.24%
Q1 2017

Mar 13, 2017

$486.40K$64.00K-86.84%-$3.77-$0.50+86.74%
Q4 2016

Nov 7, 2016

$65.33K$64.00K-2.04%-$3.80-$3.50+7.89%
Q3 2016

Aug 8, 2016

$60.36K$64.00K+6.04%-$0.52-$5.60-976.92%
Q2 2016

May 9, 2016

$77.54K$64.00K-17.46%-$0.63-$5.20-725.40%
Q1 2016

Mar 7, 2016

$61.83K$64.00K+3.51%-$5.67-$5.90-4.06%
Q4 2015

Nov 13, 2015

$66.13K$64.00K-3.23%-$0.62-$5.40-770.97%
Q3 2015

Aug 19, 2015

$63.36K$64.00K+1.01%-$0.45-$5.30-1077.78%
Q2 2015

May 15, 2015

$3.13M$3.30M+5.30%-$0.43-$7.50-1644.19%
Q1 2015

Mar 30, 2015

$8.36M$5.30M-36.62%-$0.71-$1.00-40.85%
Q4 2014

Nov 13, 2014

$5.06M$4.38M-13.46%-$0.52-$4.50-765.38%
Q3 2014

Aug 13, 2014

$4.52M$4.71M+4.01%-$0.40-$21.20-5200.00%
Q4 2013

Dec 31, 2013

$3.67M-$137.42
Q3 2013

Sep 30, 2013

$4.16M-$25.04
Q2 2013

Jun 30, 2013

$4.23M-$17.09
Q1 2013

Mar 31, 2013

$4.79M-$13.08